NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
49,950,433
Share change
+4,633,475
Total reported value
$47,172,000
Put/Call ratio
31%
Price per share
$0.94
Number of holders
71
Value change
+$4,068,782
Number of buys
25
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q1 2016

As of 31 Mar 2016, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,950,433 shares. The largest 10 holders included Platinum Management (NY) LLC, COMMERZBANK AKTIENGESELLSCHAFT /FI, VANGUARD GROUP INC, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, BlackRock Institutional Trust Company, N.A., UBS Group AG, STATE STREET CORP, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 71 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.